This multi- institute project (InterMEL consortium project) identifies molecular and clinical factors which relate to the prognosis of melanoma, with the ultimate objective of improving the treatment of advanced melanoma. The goal of the BC project is to harmonize the clinical data from all institutes.
Prognosis and risk factors of skin cancer
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.